Nevro Corp

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• KAKonstantinos AlatarisDirector · Executive Officer
• JDJohn DeedrickDirector
• MDMichael DeManeDirector · Executive Officer
• AGAndrew GalliganExecutive Officer
• BHBill HarringtonDirector
• VKVince KimDirector
• VKVincent KimDirector
• MKMark KnudsonDirector
• BMBill MoffittDirector
• NPNathan PliamDirector
• NPNick PliamDirector
• JTJon TremmelDirector

• 10 Sept 2026External Neurostimulatorapplication
• 20 Aug 2026Systems And Methods For Treating Motor Dysfunction, Including By Selectively Activating And/or Suppressing Motor Neurons And/or Motor Responsesapplication
• 25 Jun 2026Efficient Use Of An Implantable Pulse Generator Battery, And Associated Systems And Methodsapplication
• 23 Jun 2026Treatment Of Neurodegenerative Disease With High Frequency Stimulation, And Associated Systems And Methodsgranted
• 04 Jun 2026Systems And Methods For Direct Suppression Of Nerve Cellsapplication
• 04 Jun 2026Long Pulse Width Spinal Cord Stimulation For Treating Autonomic Nerve Dysfunction, And Associated Systems And Methodsapplication
• 04 Jun 2026Modified High Frequency Neuromodulation Signals, And Associated Systems And Methodsapplication
• 21 May 2026Long Pulse Width Spinal Cord Stimulation For Treating Autonomic Nerve Dysfunction, And Associated Systems And Methodsapplication
• 21 May 2026Long Pulse Width Spinal Cord Stimulation For Treating Autonomic Nerve Dysfunction, And Associated Systems And Methodsapplication
• 19 May 2026External Neurostimulatorgranted
• 30 Apr 2026Systems And Methods For Delivering Neurostimulation To Increase Blood Glucose Uptake In A Patientapplication
• 02 Apr 2026Selective High Frequency Spinal Cord Modulation For Inhibiting Pain, Including Cephalic And/or Total Body Pain With Reduced Side Effects, And Associated Systems And Methodsapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.